Aggrastat Inj.

Ingredient

Tirofiban Hydrochloride Hydrate　

Content

14.05mg/50ml (12.5mg/50ml as tirofiban)

Indication

Co-administration with heparin in the patients who are:
– target patients in the treatment of acute coronary syndrome (ACS)
– patients with percutaneous transluminal coronary angioplasty (PTCA) or atherectomy

It has been shown to reduce the incidence of death, myocardial infarction, or combined endpoints of refractory ischemia/recardiac procedures.